Issues With the Diagnosis and Classification of Hyperglycemia in Early Pregnancy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy (1). Within that document, the recommendations regarding early pregnancy testing were designed to facilitate early detection and treatment of hyperglycemia (HbA1c ≥6.5% [48 mmol/mol], fasting venous plasma glucose ≥7.0 mmol/L, random plasma glucose ≥11.1 mmol/L with confirmation) that, outside pregnancy, would be classified as diabetes. The term “overt diabetes” was suggested to describe these women. Subsequently, the World Health Organization (WHO) adopted the IADPSG criteria with some modifications and promoted the use of the term “diabetes in pregnancy” (2) for this group. Cognizant that milder degrees of hyperglycemia would also be detected by early pregnancy testing, the IADPSG also recommended that fasting …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The International Association of the Diabetes and Pregnancy Study Groups (IADPSG) GDM diagnostic criteria for the 75-g OGTT, as well as the GDM screening and diagnostic criteria used in the two-step approach, were not derived from data in the fi rst half of pregnancy and should not be used for early screening (197).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [197]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The GDM diagnostic criteria for the 75-g OGTT from the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) and the GDM screening and diagnostic criteria with the two-step approach were not derived from data in the first half of pregnancy”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [179]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Untreated glucose intolerance increases the risk of maternal and neonatal complications.”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, different cut-off values of 5.1 mmol/L 92 mg/dL or 5.3 mmol/L 95 mg/dL for the 75 g OGTT were used [2].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Offspring whose mothers had GDM are more likely to be overweight, and obese, and they may develop glucose intolerance and type 2 diabetes mellitus (T2DM) in the future [2].”
From Evolution of Gestational Diabetes Mellitus across Continents in 21st Century (2022) · cites this paper as [2]
Experimental — accuracy not yet measured
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“In 2010, the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) panel published consensus-based recommendations on the diagnosis and classification of hyperglycemia in pregnancy (1).”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Zhu, W.-W., Yang, H.-X., Wei, Y.-M., Yan, J., Wang, Z.-L., Li, X.-L., Wu, H.-R., Li, N., Zhang, M.-H., Liu, X.-H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1157 · Cited by 338 · cited 4×
“Zhu WW, Yang HX, Wei YM, et al. Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China.”
BackgroundInfluentialHughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014) · Diabetes Care · doi:10.2337/dc14-1312 · Cited by 238
Colagiuri, S., Falavigna, M., Agarwal, M. M., Boulvain, M., Coetzee, E., Hod, M., Meltzer, S. J., Metzger, B., Omori, Y., Rasa, I., et al. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.02.012 · Cited by 132
Corrado, F., D’Anna, R., Cannata, M. L., Interdonato, M. L., Pintaudi, B., & Di Benedetto, A. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.03.006 · Cited by 96 · cited 2×
“More recent data from Italy (3) and China (4), where IADPSG diagnostic criteria were applied, have strongly challenged this recommendation, demonstrating a clear fall in FPG in early pregnancy and showing that early FPG $5.”
BackgroundInfluential
Cited by
Items 101–181 of 181
Gestational Diabetes Mellitus: New Thinking on Diagnostic Criteria
Luo, J., Tong, L., Xu, A., He, Y., Huang, H., Qiu, D., Guo, X., Chen, H., Xu, L., Li, Y., et al. (2024) · Life · doi:10.3390/life14121665 · Cited by 20
“There is a higher risk of adverse pregnancy outcomes, and there are many benefits of early identification and intervention [67].”
InfluentialValizadeh, M., Hosseinpanah, F., Tehrani, F. R., Abdi, H., Mehran, L., Hadaegh, F., Amouzegar, A., Sarvghadi, F., Azizi, F., & Iranian Endocrine Society Task Force (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.107906 · Cited by 11
This is the decade to find the solution for gestational diabetes mellitus screening and treatments
Dunne, F., Lindsay, R. S., & Loeken, M. R. (2021) · Diabetic Medicine · doi:10.1111/dme.14602 · Cited by 10
Early diabetes screening in pregnancy
Shinar, S., & Berger, H. M. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12484 · Cited by 11
Cosson, E., Vicaut, É., Sandre-Banon, D., Gary, F., Pharisien, I., Portal, J.-J., Baudry, C., Cussac-Pillegand, C., Valensi, P. E., & Carbillon, L. (2019) · Diabetic Medicine · doi:10.1111/dme.14141 · Cited by 10
Rosenberg, E. A., Seely, E. W., James, K. E., Arenas, J., Callahan, M. J., CAYFORD, M., Nelson, S., Bernstein, S. N., Thadhani, R., & Powe, C. E. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108869 · Cited by 11
GESTATIONAL DIABETES MELLITUS: Challenges in diagnostics, management and impact
de Wit, L. (2020) · Utrecht University Repository (Utrecht University) · doi:10.33540/195 · Cited by 9
Huhn, E. A., Kotzaeridi, G., Fischer, T., Bernasconi, M. T., Richter, A. S., Kunze, M., Dölzlmüller, E., Jaksch‐Bogensperger, H., Weidinger, L., Eppel, D., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06517-0 · Cited by 10
“Later, some investigators claimed that there is insufficient data ‘to confidently recommend’ glucose thresholds for GDM diagnosis in the early gestational period [5].”
Does fasting plasma glucose values 5.1-5.6 mmol/l in the first trimester of gestation a matter?
Tehrani, F. R., Farzadfar, F., Hosseinpanah, F., Rahmati, M., Firouzi, F., Abedini, M., Hadaegh, F., Valizadeh, M., Torkestani, F., Khalili, D., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1155007 · Cited by 9
Cheung, K. W., Au, T. S.-T., Lee, C., Ng, V. W. Y., Wong, F. C.-K., Chow, W.-S., Hui, P. W., & Seto, M. T. Y. (2024) · AJOG Global Reports · doi:10.1016/j.xagr.2024.100315 · Cited by 12
Ozgu-Erdinc, A. S., Sert, Ü. Y., Kansu-Celik, H., Tekın, Ö. M., & Üstün, Y. E. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1671457 · Cited by 8
Egan, A. M., Hod, M., Mahmood, T. A., & Dunne, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.001 · Cited by 9
Biomarkers of Gestational Diabetes Mellitus: Mechanisms, Advances, and Clinical Utility
Pramodkumar, T. A., Hannah, W., Anjana, R. M., Ram, U., Tiwaskar, M., Gokulakrishnan, K., Popova, P. V., & Mohan, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0849 · Cited by 7
“25,26 Elevated FPG levels, reflecting hepatic insulin resistance and increased glucose production, are central to the pathophysiology of GDM. 27 However, various studies suggest that the optimal FPG cut point may vary.”
Yan, B., Yu, Y., Chen, Y.-L., Su, W., Huang, Y., Mu-lin, Z., Huang, B., Han, L.-L., Song, H., & Li, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-52509-7 · Cited by 9
McCance, D. R., & Cassidy, L. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch71 · Cited by 9
Lewandowski, K., Głuchowska, M., Garnysz, K., Horzelski, W., Grzesiak, M., & Lewiński, A. (2021) · Endokrynologia Polska · doi:10.5603/ep.a2021.0095 · Cited by 6
Punnose, J. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i10.108254 · Cited by 9
“A large retrospective cohort study among 12918 high-risk women in Hong Kong, China, reported a continuous increase in adverse pregnancy outcomes with increasing FPG and 2-hour plasma glucose (PG) levels before 24 GW[27].”
InfluentialGupta, Y., Singh, C., Goyal, A., Kalaivani, M., Bhatla, N., & Tandon, N. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02405-w · Cited by 6
“In pregnancy, the HbA1c is predominantly used for diagnosing overt diabetes in the first trimester and for evaluating control of diabetes, but has also been used for diagnosis of women at risk for adverse pregnancy outcomes [3, 9, 10].”
MethodNakanishi, S., Aoki, S., Kasai, J., Shindo, R., Obata, S., Hasegawa, Y., Mochimaru, A., Kurasawa, K., & Miyagi, E. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003230 · Cited by 8
Iwama, N., Sugiyama, T., Metoki, H., Kusaka, H., Maki, J., Nishigori, H., Yaegashi, N., Sagawa, N., Hiramatsu, Y., & Toyoda, N. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.017 · Cited by 6
Harreiter, J., & Kautzky‐Willer, A. (2016) · Wiener klinische Wochenschrift Education · doi:10.1007/s11812-016-0078-9 · Cited by 6
Yokoyama, M., Miyakoshi, K., Nakanishi, S., Iwama, N., Aoki, S., Yasuhi, I., & Sugiyama, T. (2024) · Diabetology International · doi:10.1007/s13340-024-00700-1 · Cited by 5
Gestationsdiabetes mellitus – Teil 1: Screening und Diagnostik
Kleinwechter, H. J. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00828-7 · Cited by 5
Ruiz, D., Santibáñez, M., Lavín, B. A., Álvarez, I., Berja, A., Montalbán, C., & Vázquez, L. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113003 · Cited by 7
“In fact, the ability to diagnose GDM in the first trimester remains controversial, and all parameters investigated have been poorly predictive of oral glucose tolerance test outcomes in the third trimester [27].”
BackgroundLo nuevo en diagnóstico y tratamiento de diabetes mellitus gestacional
Artavia, A. L. E., & Vaglio, R. F. (2019) · Revista Medica Sinergia · doi:10.31434/rms.v4i4.180 · Cited by 14
Diagnosis of gestational diabetes: Evidence and pitfalls
Wong, T., Immanuel, J., Wong, V. W., Barnes, R., & Simmons, D. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102069 · Cited by 4
Irish Endocrine Society 40th Annual Meeting 14th and 15th October 2016, Stormont Hotel Belfast
Egan, A. M., Vellinga, A., & Dunne, F. (2016) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-016-1482-y · Cited by 5
Amini, M., Kazemnejad, A., Rasekhi, A., Amirian, A., & Kariman, N. (2024) · Health Science Reports · doi:10.1002/hsr2.70090 · Cited by 6
Cheung, K. W., Au, T. S.-T., Chan, T. O., So, P. L., Wong, F. C.-K., & Seto, M. T. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-76497-5 · Cited by 6
“These highlighted the limitation of the current diagnostic criteria in early gestation to identify women who would require interventions for hyperglycaemia to prevent maternal and perinatal complications 14 .”
BackgroundKuehn, J., Gebuehr, A., Wintour, J., Woods, A., Luu, J. M., & Wynne, K. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13254 · Cited by 4
Gestational Diabetes Mellitus: A Narrative Review
Ali, A. I., & Nori, W. (2021) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1_21 · Cited by 5
Andrews, C., Castillo, M. T., Aktaş, H., Luque-Fernández, M. Á., Wong, S. K., Sen, S., & Halperin, J. A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-054773 · Cited by 4
Nakanishi, S., Aoki, S., Shindo, R., Obata, S., Kasai, J., & Miyagi, E. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01124-1 · Cited by 4
“9% or higher is observed in early pregnancy [4].”
BackgroundMartin, M. B., Harding, A. L., Borchard, J., & Moses, R. G. (2018) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12763 · Cited by 4
Gupta, Y., Singh, C., Goyal, A., Kalaivani, M., Bharti, J., Singhal, S., Kachhawa, G., Kulshrestha, V., Kumari, R., Mahey, R., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01317-w · Cited by 3
“In 2016, the IADPSG revised its stand and suggested that the evidence to support the use of FPG for the diagnosis of GDM in early pregnancy was not strong [6].”
MethodInaku, K. O., Ago, B. U., Ene, A. B., Eyam, E. S., Ekpe, L. E., Ogarekpe, Y. M., Babatope, O. A., & Agan, T. U. (2021) · Calabar Journal of Health Sciences · doi:10.25259/cjhs_45_2020 · Cited by 3
Olagbuji, B. N., Aderoba, A. K., Olagbuji, Y., Enikuomehin, A. C., Adewole, A., Awe, C. O., Akadiri, O., & Gestational Diabetes Study Group—Nigeria (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14102 · Cited by 4
Gestational weight gain influences neonatal outcomes in women with obesity and gestational diabetes
Ramos-Levi, A. M., Fernández‐Pombo, A., García-Fontao, C., Gómez-Vázquez, E., Cantón-Blanco, A., Olmos, M. Á. M., Andújar-Plata, P., Mariño, P. B., Rodríguez-Carnero, G., & Villar‐Taibo, R. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2022.01.005 · Cited by 5
Takemoto, A., Nagai, Y., Kawanabe, S., Nakagawa, T., Matsumoto, K., Hasegawa, J., Suzuki, N., Tanaka, Y., & Sone, M. (2023) · Diabetology International · doi:10.1007/s13340-023-00646-w · Cited by 5
“A strength of our study is that we diagnosed GDM with the IADPSG criteria after performing the national guideline-based screening because different guidelines for GDM are adopted in every country [36–39].”
MethodGestational weight gain influences neonatal outcomes in women with obesity and gestational diabetes
Ramos-Levi, A. M., Fernández‐Pombo, A., García-Fontao, C., Gómez-Vázquez, E., Cantón-Blanco, A., Olmos, M. Á. M., Andújar-Plata, P., Mariño, P. B., Rodríguez-Carnero, M. G., & Villar‐Taibo, R. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.11.018 · Cited by 6
MIHĂESCU, A., MOLDOVAN, I. D., Bărăian, A.-M., MICAŞ, A.-G., Iov, C. A., Toma, M., Leuca, Ș., Gheorghe, R. A. D. U., Botoş, H. M., Popa, P., et al. (2020) · Research and Science Today · doi:10.38173/rst · Cited by 3
Jokelainen, M., Kautiainen, H., Nenonen, A., Stach‐Lempinen, B., & Klemetti, M. M. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01290-3 · Cited by 4
“Because evidence-based, internationally accepted OGTT criteria for the diagnosis of early-onset GDM are not available [23, 24], in the present study, we focused on women ( n = 52) who required pharmacological GDM treatment at any point during pregnancy for persistent hyperglycemia in…”
BackgroundMethodChen, T., Cai, J., He, D., Zhu, H., Chen, X., Li, Y., Ye, W., Li, B., Xu, Q., Ji, L., et al. (2025) · PeerJ · doi:10.7717/peerj.19621 · Cited by 3
“…75-g oral glucose tolerance test (OGTT) according to the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria ( McIntyre et al., 2016 ), with reference to the American Diabetes Association (ADA) diagnostic guidelines ( American Diabetes Association, 2012 ).”
Katayama, A., Hasegawa, M., Morimoto, E., Watanabe, M., Matsushita, Y., Takeda, M., Kai, K., Yoshida, M., 塚原, 紗., Okimoto, N., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005114 · Cited by 3
Nakanishi, S., Aoki, S., Iwama, N., Yasuhi, I., Sugiyama, T., & Miyakoshi, K. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16108 · Cited by 2
Jamieson, E. L., Spry, E. P., Kirke, A. B., Griffiths, E. K., Porter, C., Roxburgh, C., Singleton, S., Sterry, K., Atkinson, D. N., & Marley, J. V. (2021) · Primary care diabetes · doi:10.1016/j.pcd.2021.09.011 · Cited by 3
Bernier, É., Plante, A.-S., Lemieux, P., Robitaille, J., Lemieux, S., Desroches, S., Bélanger‐Gravel, A., Maheux‐Lacroix, S., Weisnagel, S. J., Demers, S., et al. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1336509 · Cited by 2
“…whether the diagnostic criteria for tests performed between 24 and 28 weeks of gestation can be applied to tests performed in early pregnancy (32, 44), diabetes at this first visit will be diagnosed using the criteria for overt diabetes (diabetes present before pregnancy), as recommended by the…”
MethodIzumi, S., Iwama, N., Hamada, H., Obara, T., Ishikuro, M., Satoh, M., Murakami, T., Saito, M., Ohkubo, T., Sugiyama, T., et al. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej23-0568 · Cited by 3
“However, the diagnostic criteria differs depending on the country or organization because of the lack of evidence to diagnose hyperglycemia during early pregnancy [5].”
Diabetes and pregnancy: A call for terminology standardization in clinical practice
Carranza, E. A. A., Casella, J. A. L., & Concepción‐Zavaleta, M. J. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112102 · Cited by 3
Kontinuierliche Glukosemessung in der Schwangerschaft
Sontag, I., & Adamek, H. E. (2025) · Info Diabetologie · doi:10.1007/s15034-025-5170-8 · Cited by 1
“SSW) auf-tretenden „early GDM“ (eGDM) einigen [3].”
D’Souza, A., Abdullahi, H., & Ibrahim, I. I. (2026) · International Journal of Endocrinology · doi:10.1155/ije/3725182 · Cited by 2
Prediabetes before pregnancy: implications for risk stratification and research
Bhattacharya, S., Mohan, V., Nagendra, L., & Saravanan, P. (2026) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000964 · Cited by 1
Cosson, E., Haas, L. C., & Levrat‐Guillen, F. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71005 · Cited by 1
“According to the World Health Organisation (WHO) 2013 criteria [12], it falls under the umbrella of HIP, while the International Association of Diabetes and Pregnancy Study Groups (IADPSG) urged caution in 2016, citing insufficient evidence to determine long-term risk [18].”
Pszczolkowski, V. L., Youn, Y.-J., Her, T. K., & Alejandro, E. U. (2026) · Journal of Animal Science · doi:10.1093/jas/skag212 · Cited by 1
“Although early pregnancy reporting of GDM diagnosis does occur (McIntyre et al. 2016; Bochkur Dratver et al. 2022), the ADA defines diabetes diagnosis at < 15weeks gestation as non-GDM (American Diabetes Association (ADA) Professional Practice Committee for Diabetes 2026).”
Gestational diabetes mellitus and life-course health
Nazir, S. F., Mohamed, A. A. M. F., Hogan, J. L., Kennelly, M., Gallagher, J., & O'Higgins, A. C. (2026) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2026.102106 · Cited by 1
Gibt es jetzt eine Therapieindikation?
Sontag, I., & Adamek, H. E. (2023) · Info Diabetologie · doi:10.1007/s15034-023-4559-5 · Cited by 1
Value of early pregnancy HbA1c to predict gestational diabetes
Gupta, Y., & Simmons, D. S. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00160-8 · Cited by 2
Intervention to Reduce Unnecessary Glucose Tolerance Testing in Pregnant Women
Buse, J. D., Donovan, L., Naugler, C. T., Sadrzadeh, S. M. H., & de Koning, L. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026047 · Cited by 1
Diabetes Gestacional Precoz: ¿Es útil la glucemia en ayunas?
Megía, A. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.12.001 · Cited by 1
Hassan, I. M., Saidu, B., Ja’afaru, A. I., Dahiru, A., Abdulazeez, N., Yusuf, H. I., Tosin, A. H., Pilau, N. N., Abubakar, A. A., & Bello, M. B. (2021) · Advances in Biochemistry · doi:10.11648/j.ab.20210901.12 · Cited by 1
Gyermekvállalás és diabetes – 2019
Baranyi, É., & Winkler, G. (2019) · Diabetologia Hungarica · doi:10.24121/dh.2019.20 · Cited by 1
Yang, Y., & Jung, H. S. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0023 · Cited by 1
Diagnosi di diabete gestazionale: istruzioni per l’uso
Sciacca, L., & Lapolla, A. (2017) · L Endocrinologo · doi:10.1007/s40619-017-0372-5
“e non ci sono evidenze scientifiche e cliniche che tali valori possano essere utilizzati nelle prime settimane di gravidanza [3].”
BackgroundEarly gestational diabetes: Is fasting glucose useful?
Megía, A. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.12.002
MANAGEMENT OF GESTATIONAL DIABETES - A REVIEW OF CURRENT LITERATURE
Bernea, E. G., Antohe, F., Mihai, A. D., Ceauşu, I., Guja, C., & Ionescu-Tirgoviste, C. (2020) · Research and Science Today · doi:10.38173/rst.2020.19.1.11:109-123
Guo, Z., Shan, Y., Xiu, C., Yang, Y., Zheng, S., & Peng, M. (2020) · doi:10.21203/rs.3.rs-32012/v1
“Critics[12] points that mild hyperglycemia does not carry anything like the same degree of risk as overt diabetes.”
BackgroundAn Updated Review of the Gestational Diabetes
Moori, M. H. (2021) · Disease and Diagnosis · doi:10.34172/ddj.2021.22
“These women are much more likely to suffer from diabetes mellitus and cardiovascular disease later in life and their babies are more likely to be macrosomic, to have more congenital abnormalities, and to develop neonatal hypoglycemia and type 2 diabetes mellitus (T2DM) later in life (6).”
BackgroundManaging Gestational Diabetes During and After Pregnancy
Egan, A. M., & Dunne, F. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch6 · Cited by 1
Chen, Z., Huang, H., Hu, J., Wang, S., & Xia, L. (2021) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog4805192
“Insulin resistance, which has been known as one of the key pathophysiological features observed in type 2 diabetes as well as GDM [8], was found to present prior to conception and persisted across pregnancy [9], and is suggested to play a vital role in the mechanism of GDM.”
BackgroundGestational diabetes: Optimizing Dx and management in primary care
Ha (2022) · The Journal of Family Practice · doi:10.12788/jfp.0360 · Cited by 2
Paneque, A. A. E., Ortiz, M. G. C., Maldonado, E. A. D., Matute, S. G. U., Martínez, C. E. C., & Llumiquinga, P. M. Q. (2022) · doi:10.58594/dzdk6465
Jecht, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01229-2
Gestational diabetes: Current trends in treatment and long-term complications
Aleiid, A. S., Alsayyari, A. M., Albishri, A. A., Ghassap, S. A., Alamri, S. A., Almuhaylib, A. M., & Alrakhimy, H. D. (2019) · International Journal of Health Sciences · doi:10.53730/ijhs.v3ns1.15218
Seclen, S. N., Damas-Casani, L. N., Motta-Montoya, V. D. C., Jimenez-Martel, S. L., & Yovera-Aldana, M. (2025) · medRxiv · doi:10.1101/2025.01.26.25321156
“[25] This recommendation was based on an Italian study showing that only 45% of patients with fasting glucose greater than 92 mg/dl during the first trimester were positive in the OGTT between 24-28 weeks, with an area under the curve (AUROC) of 0.614.”
InfluentialHasan, M. R., Sultana, N., Panthi, S., Hasan, M., Jahan, S., & Hasanat, M. A. (2025) · Journal of Association of Clinical Endocrinologist and Diabetologist of Bangladesh · doi:10.3329/jacedb.v2i2.78441
“13,14 The IADPSG criteria for the diagnosis of GDM is adopted by the 2013 WHO criteria for GDM. Pregnancy should be planned in a society where the prevalence of T2DM is high.”
Salvatori, B., Linder, T., Eppel, D., Morettini, M., Burattini, L., Göbl, C., & Tura, A. (2022) · Figshare · doi:10.6084/m9.figshare.21359919
Jokelainen, M., Kautiainen, H., Nenonen, A., Stach‐Lempinen, B., & Klemetti, M. M. (2024) · Figshare · doi:10.6084/m9.figshare.25303048
Wu, Q., Chen, Y., Zhou, M., Liu, M., Zhang, L., Liang, Z., & Chen, D. (2022) · Figshare · doi:10.6084/m9.figshare.19029183
Wu, L., Fan, G., Zhang, L., Bi, J., Peng, J., Liu, Q., Fang, Q., Song, L., Zheng, L., Chen, S., et al. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01109-0
“…may be limited by challenges in timely intervention and uncertainty about whether hyperglycemia before 20 weeks represents true early GDM. [37, 38] In contrast, our approach leverages routinely collected data from the standard 24–28 weeks OGTT, making it more feasible for integration into…”
Early gestational diabetes mellitus: unravelling the Gordian knot
Agarwal, M., & Simmons, D. S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113502
Bomba-Opon, D. A., Cypryk, K., Czajkowski, K., Wender-Ożegowska, E., & Zozulińska‐Ziółkiewicz, D. (2026) · Diabetes Therapy · doi:10.1007/s13300-026-01906-z
“This may be inter‑ preted to suggest that the diagnostic criteria for GDM when OGTT is performed at 24–28 weeks may not apply to early GDM detection, and that other measures should be also be used, such as an HbA1c > 5.9% (41 mmol/mol) [32].”
Influential
Metadata
- Authors
- McIntyre, H. D., Sacks, D. A., Barbour, L. A., Feig, D. S., Catalano, P. M., Damm, P., & McElduff, A.
- Affiliations
- Mater Research, The University of Queensland, Brisbane, Queensland, Australia
- Kaiser Permanente (US)
- University of Colorado Denver (US)
- University of Toronto (CA)
- MetroHealth (US)
- University of Copenhagen (DK)
- The University of Sydney (AU)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-10-30
- Volume
- 39
- Issue
- 1
- Pages
- 53-54
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W1872548695
- Cited by
- 181
- References
- 6
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 24 · 2023: 8 · 2022: 26 · 2021: 21 · 2020: 19 · 2019: 17 · 2018: 24 · 2017: 11 · 2016: 9 · 2015: 1
- FWCI
- 17.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- hyperglycemia in pregnancy, early pregnancy, IADPSG criteria, diabetes in pregnancy, overt diabetes, gestational diabetes mellitus, HbA1c, fasting blood glucose, random blood glucose, diagnostic thresholds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.